A Multi-center Acute Efficacy Trial of GFX For Reduction of Glabellar Furrowing

Inclusion Criteria: * Has no medical contraindication * Presenting for correction of glabellar furrows, as classified per the Rated Numeric Kinetic Line Scale Score for Facial Wrinkles Secondary to Hyperkinetic Function (Class 1 or Higher) are candidates for this study * Is at least 18 years of age * Signs a written informed consent * Understands and accepts the obligation to present for the scheduled follow-up visit * Understands that the GFX procedure may not be successful. Exclusion Criteria: * Has had an injection of botulinum toxin to the target area within the previous 3 months and still exhibits a positive cosmetic effect to the glabellar furrow * Has had silicone, fat, collagen or a synthetic material placed in the glabellar region or surgical correction or excision of the glabellar furrows * Has a known bleeding disorder * Has received or is anticipated to receive anti-platelets, anti-coagulants thrombolytics or cancer therapy * Is receiving systemic corticosteroids or anabolic steroids (standard doses of inhaled or nasal corticosteroids are acceptable) * Has a history of chronic or recurrent infection or compromised immune system * Has severe allergies manifested by a history of anaphylaxis * Has known lidocaine hypersensitivity * Is enrolled in another study * Is Pregnant * Has history of keloid formation * The investigator believes the patient is not a suitable candidate for the GFX procedure, or is not likely to receive cosmetic benefit.